Is QLGN or DGRO a better dividend investment in 2026?

QLGN currently yields 62.31% with a 5% 5-year dividend growth rate. DGRO yields 2.13% with 9.5% growth. The better choice depends on your goal: QLGN offers higher current income.

What is the dividend yield difference between QLGN and DGRO?

QLGN has a forward dividend yield of 62.31% ($2.00/share annually). DGRO yields 2.13% ($1.47/share annually). The yield gap is 60.18 percentage points.

Home › Compare › QLGN vs DGRO

QLGN vs DGRO: Dividend Comparison 2026

QLGN yields 62.31% · DGRO yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 QLGN wins by $697.4K in total portfolio value

INVESTMENT

TIME HORIZON10 years

QLGN

● Live price

62.31%

Share price

$3.21

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$729.0K

Annual income

$175,361.30

Full QLGN calculator →

DGRO

iShares Core Dividend Growth ETF

● Live price

2.13%

Share price

$68.98

Annual div

$1.47

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.6K

Annual income

$239.96

Full DGRO calculator →

Portfolio growth — QLGN vs DGRO

📍 QLGN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	QLGN	DGRO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, QLGN + DGRO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

QLGN pays

DGRO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QLGN

Annual income on $10K today (after 15% tax)

$5,295.95/yr

After 10yr DRIP, annual income (after tax)

$149,057.10/yr

DGRO

Annual income on $10K today (after 15% tax)

$181.24/yr

After 10yr DRIP, annual income (after tax)

$203.97/yr

At 15% tax rate, QLGN beats the other by $148,853.14/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QLGN + DGRO for your $10,000?

QLGN: 50%DGRO: 50%

100% DGRO50/50100% QLGN

Portfolio after 10yr

$380.3K

Annual income

$87,800.63/yr

Blended yield

23.09%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QLGN buys

DGRO buys

No recent congressional trades found for QLGN or DGRO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricQLGNDGRO

Forward yield	62.31% ✓	2.13%
Annual dividend / share	$2.00 ✓	$1.47
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$729.0K ✓	$31.6K
Annual income after 10y	$175,361.30 ✓	$239.96
Total dividends collected	$608.8K ✓	$2.3K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: QLGN vs DGRO ($10,000, DRIP)

Year	QLGN Portfolio	QLGN Income/yr	DGRO Portfolio	DGRO Income/yr	Gap
1← crossover	$16,931	$6,230.53	$11,293	$213.22	+$5.6K → QLGN
2	$27,974	$9,858.52	$12,730	$217.32	+$15.2K → QLGN
3	$45,156	$15,223.51	$14,326	$221.10	+$30.8K → QLGN
4	$71,283	$22,966.14	$16,098	$224.56	+$55.2K → QLGN
5	$110,155	$33,882.50	$18,064	$227.74	+$92.1K → QLGN
6	$166,800	$48,934.07	$20,246	$230.65	+$146.6K → QLGN
7	$247,726	$69,249.85	$22,666	$233.30	+$225.1K → QLGN
8	$361,186	$96,119.21	$25,349	$235.73	+$335.8K → QLGN
9	$517,443	$130,974.20	$28,325	$237.94	+$489.1K → QLGN
10	$729,026	$175,361.30	$31,624	$239.96	+$697.4K → QLGN

QLGN vs DGRO: Complete Analysis 2026

QLGN — Stock

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

Full QLGN Calculator →

DGRO — ETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →

📬

Get this QLGN vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QLGN vs SCHD QLGN vs JEPI QLGN vs O QLGN vs KO QLGN vs MAIN QLGN vs VIG QLGN vs NOBL QLGN vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.